Publicaciones en las que colabora con Pilar Font Ugalde (10)

2018

  1. Variability in the prescription of biological drugs in rheumatoid arthritis in Spain: a multilevel analysis

    Rheumatology International, Vol. 38, Núm. 4, pp. 589-598

2016

  1. Centre-related variability in hospital admissions of patients with spondyloarthritis

    Rheumatology International, Vol. 36, Núm. 9, pp. 1301-1308

  2. Etoricoxib in ankylosing spondylitis: Is there a role for active patients refractory to traditional NSAIDs?

    Clinical and Experimental Rheumatology, Vol. 34, Núm. 1, pp. 94-99

2015

  1. Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain

    Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 6, pp. 633-640

2014

  1. Ankylosing spondylitis without axial progression: Analysis of associated factors

    Journal of Rheumatology, Vol. 41, Núm. 12, pp. 2409-2412

2013

  1. Diferente expresión clínica de los pacientes con espondilitis anquilosante según el sexo en función del tiempo de evolución. Datos de REGISPONSER

    Reumatologia Clinica, Vol. 9, Núm. 4, pp. 221-225

  2. Orthopedic surgery in rheumatoid arthritis in the era of biologic therapy

    Journal of Rheumatology, Vol. 40, Núm. 11, pp. 1850-1855

2012

  1. Clinical features of late-onset ankylosing spondylitis: Comparison with early-onset disease

    Journal of Rheumatology, Vol. 39, Núm. 5, pp. 1008-1012

2011

  1. Usefulness of a centralized system of data collection for the development of an international multicentre registry of spondyloarthritis

    Rheumatology, Vol. 50, Núm. 1, pp. 132-136

2009

  1. First signs and symptoms of spondyloarthritis-data from an inception cohort with a disease course of two years or less (REGISPONSER-Early)

    Rheumatology, Vol. 48, Núm. 4, pp. 404-409